首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cardiovascular research

缩写:CARDIOVASC RES

ISSN:0008-6363

e-ISSN:1755-3245

IF/分区:13.3/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引4776
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Anniek Frederike Lubberding,Simon Veedfald,Jonathan Samuel Achter et al. Anniek Frederike Lubberding et al.
Aims: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used to treat type 2 diabetes and obesity. Albeit cardiovascular outcomes generally improve, treatment with GLP-1 RAs is associated with increas...
Rongjin Yang,Banjun Ruan,Rutao Wang et al. Rongjin Yang et al.
Aims: βII spectrin is a cytoskeletal protein known to be tightly linked to heart development and cardiovascular electrophysiology. However, the roles of βII spectrin in cardiac contractile function and pathological post...
Ryosuke Sato,Mirela Vatic,Guilherme Wesley Peixoto da Fonseca et al. Ryosuke Sato et al.
In an ageing society, the importance of maintaining healthy life expectancy has been emphasized. As a result of age-related decline in functional reserve, frailty is a state of increased vulnerability and susceptibility to adverse health ou...
Lianjie Miao,Yangyang Lu,Anika Nusrat et al. Lianjie Miao et al.
Aims: The mechanisms regulating the cellular behavior and cardiomyocyte organization during ventricular wall morphogenesis are poorly understood. Cardiomyocytes are surrounded by extracellular matrix (ECM) and interact wi...
Nikoleta Pavlaki,Alexander Froese,Wener Li et al. Nikoleta Pavlaki et al.
Aims: Gene therapy with cardiac phosphodiesterases (PDEs) such as PDE4B has recently been described to effectively prevent heart failure in mice. However, exact molecular mechanisms of its beneficial effects, apart from g...
R Scott Wright,Frederick J Raal,Wolfgang Koenig et al. R Scott Wright et al.
Background and aims: Data describing the long-term efficacy, safety, and tolerability of inclisiran are limited. This was explored in ORION-8, an open-label extension study of preceding Phase 2 and Phase 3 placebo-control...